Impact Factor
4.31
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
8.08
1,145 total citations
h5-index
49
h5 depth signal
Cited share
84.7%
122 of 144
Total citations
1,145
Citation footprint
Metric signal
10.21
External metric anchor
Self-citation
0.7%
8 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
255
China
190
India
30
Italy
28
United Kingdom
24
Citing Fields of Research
Nanoparticles
289
Drug Delivery Systems
268
Polymer & Macromolecule Science
94
Immunology
73
Oncology
61
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
1,116
Articles tracked across the journal lifetime
Indexed publication set
144
122 cited publications
Last 12 months
46
4.6 publications/month
Open access share
34.8%
16 OA publications in the last year
Leading citing country
United States
255 citing publications
Leading citing field
Nanoparticles
289 citing publications
Latest tracked publication
25 September 2026
10 recent records available
Coverage & Indexing History
v1n1, Jan./Feb. 2009-
v1n1, Jan./Feb. 2009-
Research Focus & Classification
Indexed Subjects
Drug Delivery Systems
Nanoparticles
Immunology
Noncoding RNA
Biosensors
Broad Categories
Biotechnology
Nanotechnology
Polymer & Macromolecule Science
Nanoparticles
Drug Delivery Systems
Nanofibers, Scaffolds & Fabrication
Immunology
Noncoding RNA
MeSH Descriptors
Nanomedicine
Nanotechnology
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1002/wnan.70082
Open DOI
Covalent Organic Frameworks as Next‐Generation Photosensitizers: Mechanistic Underpinnings and Emerging Advances in Antimicrobial Photodynamic Therapy
Antimicrobial photodynamic therapy (aPDT) offers a non‐antibiotic strategy for combating drug‐resistant and biofilm‐associated infections, but conventional photosensitizers are limited by aggregation, poor targeting, hypoxia, and insuffi...
02
DOI 10.1002/wnan.70080
Open DOI
From Dilemma to Breakthrough: Prospects for Clinical Application of Exosome‐Hydrogel Systems in Diabetic Wound Repair
Diabetic wounds are refractory due to persistent inflammation and impaired angiogenesis, with traditional treatments having limited therapeutic effects. As promising cell‐free therapeutic agents, exosomes can regulate wound inflammation ...
03
DOI 10.1002/wnan.70081
Open DOI
Lipid‐Based Nanotherapeutics for Inflammatory Disorders: Current Progress and Future Perspectives
Aberrant inflammatory responses are crucial indicators of the onset and progression of diverse pathologies, including metabolic syndromes, autoimmune disorders, and neuroinflammation. The intrinsic intricacy and heterogeneity of these si...
04
DOI 10.1002/wnan.70079
Open DOI
Programmable Immunity: DNA Nanostructures in Cancer Immunotherapy
Despite significant progress in cancer immunotherapy, challenges such as limited immune activation, tumor immune evasion, low response rates in solid tumors and off‐target effects continue to hinder therapeutic efficacy. These challenges...
05
DOI 10.1002/wnan.70076
Open DOI
Brain‐Targeting siRNA Delivery to Tackle Alzheimer's Disease
Alzheimer's disease (AD) is a progressive neurodegenerative disorder that places an increasing burden on patients, caregivers, and healthcare systems worldwide. Current disease‐modifying therapies (DMTs) are limited by high costs, comple...
06
DOI 10.1002/wnan.70064
Open DOI
Issue Information
07
DOI 10.1002/wnan.70078
Open DOI
Breaking Physiological Barriers in Women's Health: Mucoadhesive and Stimuli‐Responsive Nanomaterials
Biomaterials are natural or synthetic molecules that exhibit biocompatibility, biodegradability, or bioresorbability. These materials are used for numerous health applications, including as drug delivery platforms. In drug delivery, biom...
08
DOI 10.1002/wnan.70071
Open DOI
Nanomedicine for Glioblastoma Therapy: Novel Insights and Future Perspectives
Glioblastoma (GBM) remains one of the most aggressive primary brain tumors, with poor prognosis, high recurrence, and limited therapeutic options. Although substantial progress has been made in drug development, effective clinical transl...
09
DOI 10.1002/wnan.70068
Open DOI
Development of Ultrasound Microbubbles and Phase Shift Microbubbles in Theranostics
Ultrasound is widely used for diagnostic imaging and therapy. Microbubbles (MB) are effective reflectors of ultrasound and cavitation enhancers, hence their roles in diagnostic and therapeutic ultrasound. MB must be of controlled size, c...
10
DOI 10.1002/wnan.70063
Open DOI
Issue Information
Bibliographical & Catalog Notes
Description based on: Vol. 1, no. 1 (Jan./Feb. 2009).; title from cover.
Latest issue consulted: Vol. 1, no. 4 (July/Aug. 2009).
Print issues ceased with v. 1, no. 4 (2011).
Also issued online.